Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Central Research Associates, LLC dba Flourish Research, Birmingham, Alabama, United States

Hope Clinical Research, Canoga Park, California, United States

Ark Clinical Research, Long Beach, California, United States

Catalina Research Institute, LLC, Montclair, California, United States

Paradigm Clinical Research Centers, LLC, San Diego, California, United States

Southwest General Healthcare Center, Fort Myers, Florida, United States

Panax Clinical Research, Miami Lakes, Florida, United States

Flourish Research Orlando, Winter Park, Florida, United States

David Kavtaradze MD, Inc, Cordele, Georgia, United States

Excel Clinical Research, Las Vegas, Nevada, United States

Diabetes and Endocrinology Associates of Stark County, Canton, Ohio, United States

Elligo Health Research, Inc., Austin, Texas, United States

Zenos Clinical Research, Dallas, Texas, United States

Synergy Group Medical, Houston, Texas, United States

Epic Clinical Research, Lewisville, Texas, United States

Diabetes & Glandular Disease Clinic, P.A., San Antonio, Texas, United States

Burke Internal Medicine and Research, Burke, Virginia, United States